Bend Research Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bend Research Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014067
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocessing and biotherapeutics, contract manufacturing and analytical sciences. Its technologies include bioavailability enhancement, modified release and inhalation. Bend Research offers pharmaceutical drug product intermediates and oral dosage forms for development and clinical trial materials such as spray-dried dispersions, hot-melt extrusion, solid nanocrystalline dispersions, and dry granulations, among others. The company operates through its offices in Bend, the US. Bend Research is headquartered in Bend, Oregon, the US.

Bend Research Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bend Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bend Research Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bend Research Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bend Research Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bend Research Inc, Medical Devices Deals, 2011 to YTD 2017 9
Bend Research Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bend Research Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Catalent Pharma Solutions Enters Into Agreement With Bend Research 11
Bend Research Enters Into An Agreement With Xcelience 12
Licensing Agreements 13
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 13
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 14
Bend Research Enters Into Licensing Agreement With Merck 15
Acquisition 16
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 16
Bend Research Inc – Key Competitors 17
Bend Research Inc – Key Employees 18
Bend Research Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bend Research Inc, Pharmaceuticals & Healthcare, Key Facts 2
Bend Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bend Research Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bend Research Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bend Research Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Bend Research Inc, Medical Devices Deals, 2011 to YTD 2017 9
Bend Research Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Catalent Pharma Solutions Enters Into Agreement With Bend Research 11
Bend Research Enters Into An Agreement With Xcelience 12
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 13
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 14
Bend Research Enters Into Licensing Agreement With Merck 15
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 16
Bend Research Inc, Key Competitors 17
Bend Research Inc, Key Employees 18
Bend Research Inc, Other Locations 19

★海外企業調査レポート[Bend Research Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • International Datacasting Corporation:企業の戦略的SWOT分析
    International Datacasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • WorleyParsons Limited:企業の戦略・SWOT・財務情報
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Japan Steel Works Ltd:企業の戦略・SWOT・財務分析
    The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report Summary The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Xi’an Catering Co., Ltd.:戦略・SWOT・企業財務分析
    Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'an Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sharp Corporation:企業の戦略・SWOT・財務情報
    Sharp Corporation - Strategy, SWOT and Corporate Finance Report Summary Sharp Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Kaken Pharmaceutical Co Ltd (4521):企業の財務・戦略的SWOT分析
    Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Phatra Leasing Public Company Limited (PL):企業の財務・戦略的SWOT分析
    Phatra Leasing Public Company Limited (PL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Elcam Medical:企業の製品パイプライン分析2018
    Summary Elcam Medical (Elcam) is a medical device company that produces disposable medical devices and components for the OEM market, and provides novel solutions for specialized flow control needs. The company offers products, which are used in the areas of intensive care medicine, anesthesia, infe …
  • Beth Israel Deaconess Medical Center Inc-医療機器分野:企業M&A・提携分析
    Summary Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics sup …
  • Baker Hughes, a GE Co LLC (BHGE):石油・ガス:M&Aディール及び事業提携情報
    Summary Baker Hughes, a GE Co LLC (BHGE), formerly Baker Hughes Inc, a subsidiary of General Electric Co is a provider of oil and gas equipment and services. Its portfolio includes drilling equipment, subsea production systems, pipe systems, compressors, electric generators, energy recovery and stor …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology …
  • GOBARTO S.A.:企業の戦略・SWOT・財務情報
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Episurf Medical AB (EPIS B):医療機器:M&Aディール及び事業提携情報
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PanaHome Corp:企業の戦略的SWOT分析
    PanaHome Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Advanced Technology Company (ATC):企業の財務・戦略的SWOT分析
    Advanced Technology Company (ATC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Celsion Corp (CLSN):医療機器:M&Aディール及び事業提携情報
    Summary Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆